Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
Brand: Hydroxocobalamin PANPHARMA
10.1002/chem.201701738 Chem
Cardiovascular Emerging Evidence Evidence Rating: Emerging (Preliminary animal data) Cardiovascular applications are less studied but intriguing: Cardiac protection Arrhythmia prevention Blood vessel healing Collateral vessel formation Regulatory Status FDA Classification BPC-157 is not approved by the FDA for any medical use in humans
A quick and easy injectable treatment to boost energy levels
In addition to use on the face, one study of GHK-Cu applied to the skin of the thigh also noted improvement in lines, wrinkles, skin density, and even improvements in mottled pigmentation
The evidence was based on experimental data only briefly described in the patent and included models of: gastric ulcers, heart damage, liver damage, pancreatic injury, kidney damage, experimental diabetes, fever, edema, rhinitis, bone fracture, burns, skin wounds, hypersensitivity reactions, pupil dilation, colon injury, tumour growth, radiation injury, red blood cell development, fertility and lactation, tooth damage, several types of central and peripheral nerve damage, and survival from infection with Trichinosis (i.e., tapeworms) as well as several viruses
US$ 23.48
US$ 22.08
US$ 20.07
US$ 22.15
US$ 26.68
US$ 20.09
US$ 22.53
US$ 25.56
US$ 24.69